Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription


3 Int J Neurosci
1 J Neural Transm (Vienna)
1 J Neurochem
1 J Neuropsychol
2 J Neurosci
8 Mov Disord
1 Nat Rev Neurol
1 Neurochem Res
1 Neurologia (Engl Ed)
3 Neurology
2 Neurosci Lett
1 Neuroscience
4 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Int J Neurosci

  1. ZHAI H, Zheng Y, He Y, Zhang Y, et al
    A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the SLC18A2 gene.
    Int J Neurosci. 2021 Jun 2:1-4. doi: 10.1080/00207454.2021.1938036.
    PubMed         Abstract available

  2. WANG H, Gao H
    Protective effects of repetitive transcranial magnetic stimulation against 6-OHDA-induced Parkinson's symptoms in a mice model: the key role of miR-409-3p/PDHB axis.
    Int J Neurosci. 2021 Jun 2:1-10. doi: 10.1080/00207454.2021.1938037.
    PubMed         Abstract available

  3. TCHAIKOVSKY I, Lucena MM, da Costa BDSA, Garcia-Cairasco N, et al
    Behavior and electrophysiological effects on striatum-nigra circuit after high frequency stimulation. Relevance to Parkinson and Epilepsy.
    Int J Neurosci. 2021 Jun 4:1-11. doi: 10.1080/00207454.2021.1929216.
    PubMed         Abstract available

    J Neural Transm (Vienna)

  4. BIAGIONI F, Ferese R, Giorgi FS, Modugno N, et al
    An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease.
    J Neural Transm (Vienna). 2021 Jun 9. pii: 10.1007/s00702-021-02364.
    PubMed         Abstract available

    J Neurochem

  5. KHAIRNAR A, Ruda-Kucerova J, Arab A, Hadjistyllis C, et al
    Diffusion kurtosis imaging detects the time-dependent progress of pathological changes in the oral rotenone mouse model of Parkinson's disease.
    J Neurochem. 2021 Jun 9. doi: 10.1111/jnc.15449.
    PubMed         Abstract available

    J Neuropsychol

  6. CARLESIMO GA, Taglieri S, Zabberoni S, Scalici F, et al
    Subjective organization in the episodic memory of individuals with Parkinson's disease associated with mild cognitive impairment.
    J Neuropsychol. 2021 Jun 5. doi: 10.1111/jnp.12256.
    PubMed         Abstract available

    J Neurosci

  7. LIU W, Wang C, He T, Su M, et al
    Substantia nigra integrity correlates with sequential working memory in Parkinson's disease.
    J Neurosci. 2021 Jun 4. pii: JNEUROSCI.0242-21.2021.
    PubMed         Abstract available

  8. MILLER KM, Patterson JR, Kochmanski J, Kemp CJ, et al
    Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS.
    J Neurosci. 2021;41:2039-2052.
    PubMed         Abstract available


    Robots Induce Parkinson Disease Hallucinations.
    JAMA. 2021;325:2243.

    Mov Disord

  10. HAMID E, Ayele BA, Massi DG, Ben Sassi S, et al
    Availability of Therapies and Services for Parkinson's Disease in Africa: A Continent-Wide Survey.
    Mov Disord. 2021 Jun 3. doi: 10.1002/mds.28669.
    PubMed         Abstract available

  11. ISONAKA R, Goldstein DS, Zhu W, Yoon E, et al
    alpha-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease.
    Mov Disord. 2021 Jun 2. doi: 10.1002/mds.28667.
    PubMed         Abstract available

  12. CARVALHO V, Ferreira JJ, Correia Guedes L
    Tremor and Parkinsonism in Chromosomopathies - A Systematic Review.
    Mov Disord. 2021 May 31. doi: 10.1002/mds.28663.
    PubMed         Abstract available

  13. CONEYS R, Storm CS, Kia DA, Almramhi M, et al
    Mendelian Randomisation Finds No Causal Association between Urate and Parkinson's Disease Progression.
    Mov Disord. 2021 May 31. doi: 10.1002/mds.28662.
    PubMed         Abstract available

  14. BOUALI-BENAZZOUZ R, Benazzouz A
    Covid-19 Infection and Parkinsonism: Is There a Link?
    Mov Disord. 2021 May 27. doi: 10.1002/mds.28680.
    PubMed         Abstract available

  15. SEGER AD, Farrher E, Doppler CEJ, Gogishvili A, et al
    Putaminal y-Aminobutyric Acid Modulates Motor Response to Dopaminergic Therapy in Parkinson's Disease.
    Mov Disord. 2021 Jun 7. doi: 10.1002/mds.28674.
    PubMed         Abstract available

  16. MUNOZ-DELGADO L, Macias-Garcia D, Jesus S, Martin-Rodriguez JF, et al
    Peripheral Immune Profile and Neutrophil-to-Lymphocyte Ratio in Parkinson's Disease.
    Mov Disord. 2021 Jun 8. doi: 10.1002/mds.28685.
    PubMed         Abstract available

  17. MAITI B, Rawson KS, Tanenbaum AB, Koller JM, et al
    Functional Connectivity of Vermis Correlates with Future Gait Impairments in Parkinson's Disease.
    Mov Disord. 2021 Jun 10. doi: 10.1002/mds.28684.
    PubMed         Abstract available

    Nat Rev Neurol

    Gene therapy effective in model of infantile parkinsonism.
    Nat Rev Neurol. 2021 Jun 3. pii: 10.1038/s41582-021-00522.

    Neurochem Res

  19. LIU X, Wang C, Liu W, Song S, et al
    Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
    Neurochem Res. 2021 Jun 7. pii: 10.1007/s11064-021-03363.
    PubMed         Abstract available

    Neurologia (Engl Ed)

  20. GARCIA RUIZ PJ, Ruiz Lopez M, Feliz CE
    On the reversibility of parkinsonian tremor. Brief review and hypothesis.
    Neurologia (Engl Ed). 2021 May 22. pii: S0213-4853(21)00062.


    Prevalent Nonmotor Symptoms Associated With Huntington Disease: Challenging to Interpret and With Early Impact on Function.
    Neurology. 2021;96:875-876.

  22. DONADIO V, Wang Z, Incensi A, Rizzo G, et al
    In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
    Neurology. 2021;96:e2513-e2524.
    PubMed         Abstract available

  23. BOVE F, Mulas D, Cavallieri F, Castrioto A, et al
    Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease.
    Neurology. 2021 Jun 2. pii: WNL.0000000000012246.
    PubMed         Abstract available

    Neurosci Lett

  24. NIYOMRAT K, Cheaha D, Nukitram J, Kumarnsit E, et al
    Locomotor activity and resting local field potential oscillatory rhythms of 6-OHDA mouse model of Parkinson's disease in response to acute and repeated treatments with L-dopa.
    Neurosci Lett. 2021 Jun 4:136007. doi: 10.1016/j.neulet.2021.136007.
    PubMed         Abstract available

  25. WERNICK AI, Walton RL, Soto-Beasley AI, Koga S, et al
    Investigating ELOVL7 coding variants in multiple system atrophy.
    Neurosci Lett. 2021;749:135723.
    PubMed         Abstract available


    Potential non-invasive brain stimulation targets to alleviate freezing of gait in Parkinson's disease.
    Neuroscience. 2021 Jun 5. pii: S0306-4522(21)00284.
    PubMed         Abstract available

    PLoS One

  27. RODRIGUEZ-SABATE C, Rodriguez M, Morales I
    Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease.
    PLoS One. 2021;16:e0252565.
    PubMed         Abstract available

  28. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Correction: Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2021;16:e0252988.
    PubMed         Abstract available

  29. SHENG MZ, Fang TC, Chen YH, Chang MH, et al
    Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?
    PLoS One. 2021;16:e0252451.
    PubMed         Abstract available

  30. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.